DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Naing A, Lorusso P, Fu S. et al.
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma.
Br J Cancer 2013;
108: 826-830
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.